Liquidia Corporation (LQDA)

Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Liquidia Corporation (LQDA)

LQDA Investors with $100,000 in Losses Have Opportunity to Join Liquidia Corporation Fraud Investigation with SBS Law

LQDA Investors with $100,000 in Losses Have Opportunity to Join Liquidia Corporation Fraud Investigation with SBS Law

LIQUIDIA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Liquidia Corporation on Behalf of Liquidia Stockholders and Encourages Investors to Contact the Firm

LIQUIDIA CORPORATION INVESTIGATION: LQDA Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights

LQDA SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Liquidia Corporation

Liquidia Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Liquidia (LQDA)

Liquidia (NASDAQ:LQDA) Stock Price Down 6.1% After Analyst Downgrade

Liquidia Stock Plunges 57% on UTHR Patent Litigation Setback

UTHR Prevails in LQDA's Yutrepia Patent Dispute, Stock Up Nearly 13%

United Therapeutics Won Its Patent War and Liquidia Collapsed

United Therapeutics Stock Rises Following Federal Court Patent Victory Over Liquidia

United Therapeutics Corporation Prevails in Patent Litigation Against Liquidia

Liquidia slumps after US court rules for United Therapeutics in patent fight

Liquidia: Bullish On Their Growth Potential Despite YUTREPIA's Legal Tail Risk

LQDA versus ALKS: Which Biotech Stock Is the Better Buy Now?

Liquidia Provides Update on Hatch-Waxman Litigation Tied to ‘327 Patent

Liquidia (NASDAQ:LQDA) Shares Up 4.2% – Time to Buy?

Is It Too Late to Buy Liquidia Corp (LQDA) After 7.7% Rally? GF Value Says Undervalued

Can LQDA's Yutrepia Outpace Intensifying PAH Competition?